3Ge ZD, He GW. Altered endothelium-deverated hyperpolarizing factor-mediated endothelial function in coronary microarteries by St Thomas ' Hospital solution. J Thorac Cardiovasc Surg, 1999,118:173-180.
4He GW, Yang CQ. Impaired endothelium-derived hyperpolarizing factor-mediated relaxation in coronary arteries cold storage with University of Wisconsin solution. J Thorac Cardiovasc Surg,1998,116:122-130.
5Hopkinson DN,Bhabra MS,Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant, 1998,17: 525-531.
6Pearl JM, Laks H, Drinkwater DC, et al. Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution. J Thorac Cardiovasc Surg, 1994,107 : 257-264.
7Ge ZD, He GW. Comparison of University of Wisconsin and St Thomas' Hospital solutions on endothelium-derived hyperpolarizing factor-mediated function in coronary micro-arteries. Transplantation, 2000,70: 22-31.
8Zou W, Yang Q,Anthony PC Yim, et al. Impaired EDHF-mediated relaxation in porcine pulmonary micro-arteries by cold storage with University of Wisconsin and Euro-Collins solutions. J Thorac Cardiovasc Surg, 2003,126 : 208-215.
9Stig S, Trygve S, Leif P, et al. Transplantation of lung from a non-heart-beating donor. Lancet, 2001,357:825-829.
10Egan TM, Cooper JD. Lung transplantation. Ann Thorac Surg, 1989;48:741.
